CD1-mediated antigen presentation of glycosphingolipids

Microbes and Infection

Volumn 2, Issue 6, 2000, Pages 621-631

  Naidenko, Olga V ^a   Koezuka, Yasuhiko ^b   Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

Antigen presentation; CD1; Glycolipid

Indexed keywords

CD1 ANTIGEN; GLYCOSPHINGOLIPID;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; HUMAN; IMMUNOREGULATION; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

MAMMALIA;

EID: 0034047776     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00363-4     Document Type: Review

References (109)

1. Porcelli S.A. The CD1 family: a third lineage of antigen-presenting molecules. Adv. Immunol. 8:1995;1-98.
2. Hughes A.L. Evolutionary origin and diversification of the mammalian CD1 antigen genes. Mol. Biol. Evol. 17:1991;185-201.
3. Porcelli S.A., Modlin R.L. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 160:1999;297-329.
4. Park S.H., Roark J.H., Bendelac A. Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 37:1998;3128-3134.
5. Calabi F., Bradbury A. The CD1 system. Tissue Antigens. 159:1991;1-9.
6. Brossay L., Jullien D., Cardell S., et al. mCD1 is mainly expressed on hemopoietic derived cells. J. Immunol. 160:1997;1216-1224.
7. Roark J.H., Park S.H., Jayawardena J., et al. CD1,1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 35:1998;3121-3127.
8. Mandal M., Chen X.R., Alegre M.L., et al. Tissue distribution, regulation and intracellular localization of murine CD1 molecules. Mol. Immunol. 161:1998;525-536.
9. Amano M., Baumgarth N., Dick M.D., et al. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: β2-microglobulin-dependent and independent forms. J. Immunol. 250:1998;1710-1717.
10. Bleicher P.A., Balk S.P., Hagen S.J., et al. Expression of murine CD1 on gastrointestinal epithelium. Science. 147:1990;679-682.
11. Blumberg R.S., Terhost C., Bleicher P. Expression of a non polymorphic MHC class-I-like molecule, CD1d, by human intestinal epithelial cells. J. Immunol. 80:1991;2518-2524.
12. Canchis P.W., Bhan A.K., Landau S.B., et al. Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d. Immunology. 273:1993;561-565.
13. Sugita M., Jackman R.M., Van Donselaar E., et al. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science. 6:1996;349-352.
14. Prigozy T.I., Sieling P.A., Clemens D., et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity. 8:1997;187-197.
15. Jackman R.M., Stenger S., Lee A., et al. The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity. 160:1998;341-351.
16. + targets. J. Immunol. 189:1998;3681-3688.
17. Chiu Y.H., Jayawardena J., Weiss A., et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. M. 162:1999;103-110.
18. Rodionov D.G., Nordeng T.W., Pedersen K., et al. A critical tyrosine residue in the cytoplasmic tail is important for CD1d internalization but not for its basolateral sorting in MDCK cells. J. Immunol. 277:1999;1488-1495.
19. Zeng Z.H., Castaño A.R., Segelke B.W., et al. The crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science. 19:1997;339-345.
20. Porcelli S.A., Segelke B.W., Sugita M., et al. The CD1 family of lipid antigen-presenting molecules. Immunol. Today. 279:1998;362-368.
21. Joyce S., Woods A.S., Yewdell J.W., et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science. 161:1998;1541-1544.
22. Brossay L., Naidenko O., Burdin N., et al. Cutting Edge : Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J. Immunol. 269:1998;5124-5128.
23. Castaño A.R., Tangri S., Miller J.E., et al. Peptide binding and presentation by mouse CD1. Science. 187:1995;223-226.
24. Lee D.J., Abeyratne A., Dacarson C.O. Induction of an antigen-specific CD1-restricted cytotoxic T lymphocyte response in vivo. J. Exp. M. 95:1998;433-438.
25. Tangri S., Brossay L., Burdin N., et al. Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing. Proc. Natl. Acad. Sci. USA. 6:1998;14314-14319.
26. + T cell development and early IL-4 production in CD1-deficient mice. Immunity. 275:1997;459-467.
27. Smiley S.T., Kaplan M.H., Grusby M.J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science. 6:1997;977-979.
28. Mendiratta S.J., Martin W.D., Hong S., et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 162:1997;469-477.
29. Chen Y.H., Wang B., Chun T., et al. Expression of CD1d2 on thymocytes is not sufficient for the development of NK T cells in CD1d1-deficient mice. J. Immunol. 190:1999;4560-4566.
30. + intestinal intraepithelial lymphocytes in the absence of both classical major histocompatibility complex class I and nonclassical CD1 molecules. J. Exp. M. 163:1999;885-890.
31. + T cells are found in intestinal intraepithelial lymphocytes of mice that lack classical MHC class I molecules. J. Immunol. 268:1999;4100-4104.
32. + T lymphocytes. Science. 186:1995;863-865.
33. + CD4-CD8- T cells. J. Exp. M. 15:1997;109-120.
34. Bendelac A., Rivera M.N., Park S.H., Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity and function. Annu. Rev. Immunol. 180:1997;535-562.
35. + and CD4-8-T cells in mice and humans. J. Exp. M. 7:1994;1097-1106.
36. + T cell populations. Int. Immunol. 89:1995;1157-1161.
37. +CD8- single-positive thymocyte subpopulation that expresses a highly skewed T cell antigen receptor family. Proc. Natl. Acad. Sci. USA. 178:1992;6506-6510.
38. Porcelli S., Yockey C.E., Brenner M.B., Balk S.P. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- α/β T cells demonstrates preferential use of several V b genes and an invariant TCR a chain. J. Exp. M. 180:1993;1-16.
39. Dellabona P., Padovan E., Casorati G., et al. An invariant Vα24-JαQ/Vβ11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J. Exp. M. 263:1994;1171-1176.
40. + thymocytes selected by MHC class I molecules. Science. 180:1994;1774-1778.
41. + cells in the liver of mice. J. Exp. M. 270:1994;699-704.
42. + T cells in a TH2 response and in immunoglobulin E production. Science. 162:1995;1845-1847.
43. Eberl G., Lees R., Smiley S.T., et al. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 163:1999;6410-6419.
44. + natural T cells with distinct cytotoxic activities and Th1, Th2, Th0 cytokine secretion patterns. J. Immunol. 189:1999;2314-2321.
45. + T cells reciprocally regulate acute graft versus host disease. J. Exp. M. 182:1999;1073-1081.
46. + T cells by CD1-expressing cortical thymocytes. J. Exp. M. 160:1995;2091-2096.
47. + cells. J. Immunol. 189:1998;1158-1165.
48. Chang C.S., Brossay L., Kronenberg M., Kane K.P. The murine nonclassical class I major histocompatibility complex-like CD1,1 molecule protects target cells from lymphokine-activated killer cell cytolysis. J. Exp. M. 28:1999;483-491.
49. Couedel C., Peyrat M.A., Brossay L., et al. Diverse CD1d-restricted reactivity patterns of human T cells bearing 'invariant' AV24BV11 TCR. Eur. J. Immunol. 188:1998;4391-4397.
50. Brossay L., Chioda M.C., Burdin N., et al. CD1d-mediated recognition of a-galactosylceramide by NK T cells is highly conserved through mammalian evolution. J. Exp. M. 179:1998;1521-1528.
51. + T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. M. 92:1994;1285-1295.
52. + T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA. 183:1995;11931-11934.
53. + T cells upon NKR-P1 cross-linking. J. Exp. M. 158:1996;2391-2396.
54. + T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 188:1997;5112-5119.
55. Exley M., Sporcelli S., Furman M., et al. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant Vα24JαQ T cell receptor a chains. J. Exp. M. 186:1998;867-876.
56. + T cells. J. Exp. M. 278:1997;1957-1963.
57. Cui J., Shin T., Kawano T., et al. Requirement for Va14 NKT cells in IL-12-mediated rejection of tumors. Science. 160:1997;1623-1626.
58. + T cells in IL-12-induced immune responses in vivo. J. Immunol. 28:1998;16-19.
59. Leite-De-Moraes M.C., Moreau G., Arnould A., et al. IL-4-producing NK T cells are biased towards IFN-γ production by IL- 12, Influence of the microenvironment on the functional capacities of NK T cells. Eur. J. Immunol. 184:1998;1507-1515.
60. + T cells are not essential for T helper cell 2 immune responses. J. Exp. M. 157:1996;1295-1304.
61. + NK1.1-T cell population. J. Immunol. 184:1996;4421-4427.
62. Zhang Y., Rogers K.H., Lewis D.B. β2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J. Exp. M. 188:1996;1507-1512.
63. Lehuen A., Lantz O., Beaudoin L., et al. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. M. 162:1998;1831-1839.
64. Szalay G., Ladel C.H., Blum C., et al. Cutting Edge: Anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-β2 and Th1 cytokines and ameliorates listeriosis in mice. J. Immunol. 26:1999;6955-6958.
65. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 187:1996;2989-2998.
66. + CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. M. 391:1998;1047-1056.
67. Wilson S.B., Kent S.C., Patton K.T., et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature. 156:1998;177-181.
68. + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 27:1996;4035-4040.
69. + T lymphocytes. Eur. J. Immunol. 283:1997;183-188.
70. Schofield L., Mc Conville M.J., Hansen D., et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science. 95:1999;225-229.
71. Kawano T., Jcui J., Koezuka Y., et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Va14 NKT cells. Proc. Natl. Acad. Sci. USA. 182:1998;5690-5693.
72. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. M. 162:1995;993-1004.
73. Behar S.M., Podrebarac T.A., Roy C.J., et al. Diverse TCRs recognize murine CD1. J. Immunol. 278:1999;161-167.
74. Kawano T., Cui J., Koezuka Y., et al. CD1d-restricted and TCR-mediated activation of Vα14 NK T cells by glycosylceramides. Science. 161:1997;1626-1629.
75. Burdin N., Brossay L., Koezuka Y., et al. Selective ability of mouse CD1 to present glycolipids: a-galactosylceramide specifically stimulates Vα14 NK T lymphocytes. J. Immunol. 188:1998;3271-3281.
76. Spada F.M., Koezuka Y., Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. M. 60:1998;1529-1534.
77. Nieda M., Nicol A., Koezuka Y., et al. Activation of human Vα24 NKT cells by a-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner. Hum. Immunol. 50:1999;10-19.
78. Natori T., Morita M., Akimoto K., Koezuka Y. Agelasphins, novel antitumor and immunotimulatory cerebrosides from the marine sponge Agelas Mauritianus. Tetrahedron. 26:1994;2771-2784.
79. Young W.W. Jr. Molecular approaches to studying the intracellular trafficking of glycosphingolipids. Adv. Lipid Res. 34:1993;161-179.
80. Akimoto K., Natori T., Morita M. Synthesis and stereochemistry of agelasphin-9β Tetrahedron Lett. 34:1993;5593-5596.
81. Natori T., Koezuka Y., Higa T. Agelasphins, novel a-galactosylceramides from the marine sponge Agelas Mauritianus. Tetrahedron Lett. 67:1993;5591-5592.
82. Dickson R.C. Sphingolipid functions in Saccharomyces cerevisiae: comparison to mammals. Annu. Rev. Biochem. 71:1998;27-48.
83. Sonnino S., Cantu L., Corti M., et al. Aggregative properties of gangliosides in solution. Chem. Phys. Lipids. 38:1994;21-45.
84. Morita M., Motoki K., Akimoto K., et al. Structure-activity relationship of a-galactosylceramides against B16-bearing mice. J. Med. Chem. 42:1995;2176-2187.
85. Sakai T., Naidenko O.V., Iijima H., et al. Syntheses of biotinylated a-galactosylceramides and their effects on the immune system and CD1 molecules. J. Med. Chem. 190:1999;1836-1841.
86. Naidenko O.V., Maher J.K., Ernst W.A., et al. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J. Exp. M. 5:1999;1069-1080.
87. Motoki K., Kobayashi E., Uchida T., et al. Antitumor activities of α-, β-monogalactosylceramides and four diastereomers of an a-galactosylceramide. Bioorg. Med. Chem. Lett. 41:1995;705-710.
88. Sakai T., Ueno H., Natori T., et al. Effects of α- and β-galactosylated C2-ceramides on the immune system. J. Med. Chem. 4:1998;650-652.
89. Kobayashi E., Motoki K., Yamaguchi Y., et al. Enhancing effects of α-, β-monoglycosylceramides on natural killer cell activity. Bioorg. Med. Chem. 18:1996;615-619.
90. Motoki K., Morita M., Kobayashi E., et al. Immunostimulatory and antitumor activities of monoglycosylceramides having various sugar moieties. Biol. Pharm. Bull. 6:1995;1487-1491.
91. Iijima H., Kimura K., Sakai T., et al. Structure-activity relationship and conformational analysis of monoglycosylceramides on the syngeneic mixed leukocyte reaction. Bioorg. Med. Chem. 372:1998;1905-1910.
92. + T cells. Nature. 278:1994;691-694.
93. Moody D.B., Reinhold B.B., Guy M.R., et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science. 25:1997;283-286.
94. Fredman P. Glycosphingolipid tumor antigens. Adv. Lipid Res. 22:1993;213-234.
95. Fredman P., Lekman A. Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders. Neurochem. Res. 10:1997;1071-1083.
96. Speir J.A., Abdel-Motal U.M., Jondal M., Wilson I.A. Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL. Immunity. 10:1999;51-61.
97. Glithero A., Tormo J., Haurum J.S., et al. Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity. Immunity. 5:1999;63-74.
98. Uchimura A., Shimizu T., Morita M., et al. Immunostimulatory activities of monoglycosylated a-D-pyranosylceramides. Bioorg. Med. Chem. 5:1997;2245-2249.
99. Uchimura A., Shimizu T., Nakajima M., et al. Immunostimulatory activities of mono- or diglycosylated α-galactosylceramides. Bioorg. Med. Chem. 29:1997;1447-1452.
100. Shamshiev A., Donda A., Carena I., et al. Self glycolipids as T-cell autoantigens. Eur. J. Immunol. 67:1999;1667-1675.
101. Battistini L., Fischer F.R., Raine C.S., Brosnan C.F. CD1b is expressed in multiple sclerosis lesions. J. Neuroimmunol. 29:1996;145-151.
102. Burdin N., Brossay L., Kronenberg M. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 8:1999;2014-2025.
103. Motoki K., Maeda K., Ueno H., et al. Antitumor activities of combined treatment with a novel immunomodulator, (2S, 3S, 4R)-1-O-(α-D-galactopyranosyl)-2-(N- hexacosanoylamino)-1, 3, 4 - octadecanetriol (KRN7000), radiotherapy in tumor-bearing mice. Oncol. Res. 1113:1996;155-162.
104. Hoekstra D., Kok J.W. Trafficking of glycosphingolipids in eukaryotic cells; sorting and recycling of lipids. Biochim. Biophys. Acta. 144:1992;277-294.
105. Mukherjee S., Soe T.T., Maxfield F.R. Endocytic sorting of lipid analogues differing solely in the chemistry of their hydrophobic tails. J. Cell Biol. 189:1999;1271-1284.
106. Behar S.M., Dascher C.C., Grusby M.J., et al. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. M. 96:1999;1973-1980.
107. Apostolou I., Takahama Y., Belmant C., et al. Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. USA. 29:1999;5141-5146.
108. + natural killer T cells by Mycobacterium bovis bacillus Calmette Guerin. Eur. J. Immunol. 29:1999;650-659.
109. Hedlund M., Duan R.D., Nilsson A., Svanborg C. Sphingomyelin, glycosphingolipids and ceramide signalling in cells exposed to P-fimbriated Escherichia coli. Mol. Microbiol. 1998;1297-1306.